- Home
- POAI vs HOTH Comparison
POAI vs HOTH Comparison
Compare POAI & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- HOTH
- Stock Information
- Founded
- POAI 2002
- HOTH 2017
- Country
- POAI United States
- HOTH United States
- Employees
- POAI N/A
- HOTH N/A
- Industry
- POAI Industrial Specialties
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- HOTH Health Care
- Exchange
- POAI Nasdaq
- HOTH Nasdaq
- Market Cap
- POAI 4.9M
- HOTH 5.8M
- IPO Year
- POAI N/A
- HOTH 2019
- Fundamental
- Price
- POAI $0.71
- HOTH $0.84
- Analyst Decision
- POAI Hold
- HOTH Strong Buy
- Analyst Count
- POAI 1
- HOTH 4
- Target Price
- POAI N/A
- HOTH $4.75
- AVG Volume (30 Days)
- POAI 98.3K
- HOTH 1.2M
- Earning Date
- POAI 11-12-2024
- HOTH 12-24-2024
- Dividend Yield
- POAI N/A
- HOTH N/A
- EPS Growth
- POAI N/A
- HOTH N/A
- EPS
- POAI N/A
- HOTH N/A
- Revenue
- POAI $1,484,223.00
- HOTH N/A
- Revenue This Year
- POAI N/A
- HOTH N/A
- Revenue Next Year
- POAI $569.48
- HOTH N/A
- P/E Ratio
- POAI N/A
- HOTH N/A
- Revenue Growth
- POAI N/A
- HOTH N/A
- 52 Week Low
- POAI $0.55
- HOTH $0.58
- 52 Week High
- POAI $3.76
- HOTH $1.73
- Technical
- Relative Strength Index (RSI)
- POAI 47.04
- HOTH 42.94
- Support Level
- POAI $0.69
- HOTH $0.82
- Resistance Level
- POAI $0.80
- HOTH $0.84
- Average True Range (ATR)
- POAI 0.06
- HOTH 0.04
- MACD
- POAI -0.01
- HOTH -0.00
- Stochastic Oscillator
- POAI 25.93
- HOTH 14.50
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.